# Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition

> **NCT02291367** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 76 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** Cymbalta®

## Key facts

- **NCT ID:** NCT02291367
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2014-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02291367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02291367, "Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02291367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*